Home › Heart Failure › South Carolina › Columbia
Heart Failure clinical trials in Columbia, SC
5 studies for Heart Failure are looking for participants at sites in and around Columbia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
RecruitingPhase 3
- Research Site, Columbia
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
RecruitingObservational study
- Columbia, Columbia
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Recruiting
- Prisma Health Midlands, Columbia
Precision Rehabilitation for Veterans With (HFpEF)
RecruitingObservational study
- Columbia VA Health Care System, Columbia
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
RecruitingObservational study
- Prisma Health, Columbia
About Heart Failure
Heart failure, or congestive heart failure (CHF), means the heart can't pump enough blood. Learn about the signs, symptoms, and causes.
More about Heart Failure on MedlinePlus
Heart Failure trials in other cities
- New York City, NY51 studies
- Boston, MA44 studies
- Dallas, TX42 studies
- Houston, TX36 studies
- Cleveland, OH33 studies
- Chicago, IL31 studies
- Philadelphia, PA31 studies
- San Francisco, CA29 studies
- St. Louis, MO26 studies
- Durham, NC26 studies
- Atlanta, GA25 studies
- Kansas City, MO25 studies
Other studies in Columbia
- Obesity9 studies
- Overweight8 studies
- Stroke7 studies
- Disorders of Excessive Somnolence7 studies
- Cardiovascular Disease6 studies
- Macular Degeneration6 studies
- Narcolepsy6 studies
- Steatotic Liver Disease5 studies
- Burkitt Lymphoma5 studies
- High Blood Pressure5 studies
- Aphasia5 studies
- Idiopathic Hypersomnia5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.